-
Something wrong with this record ?
Rapid Purification of Endotoxin-Free RTX Toxins
O. Stanek, J. Masin, R. Osicka, D. Jurnecka, A. Osickova, P. Sebo,
Language English Country Switzerland
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 2009
Free Medical Journals
from 2009
PubMed Central
from 2009
Europe PubMed Central
from 2009
ProQuest Central
from 2009-01-01
Open Access Digital Library
from 2009-01-01
Open Access Digital Library
from 2009-01-01
Medline Complete (EBSCOhost)
from 2010-09-01
Health & Medicine (ProQuest)
from 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2009
- MeSH
- Bacterial Proteins isolation & purification toxicity MeSH
- Cytotoxins isolation & purification toxicity MeSH
- Detergents chemistry MeSH
- Erythrocytes drug effects MeSH
- Escherichia coli metabolism MeSH
- Hemolysis MeSH
- Hemolysin Proteins isolation & purification toxicity MeSH
- Humans MeSH
- Lipopolysaccharides analysis MeSH
- Urea chemistry MeSH
- Cell Line, Tumor MeSH
- Octoxynol chemistry MeSH
- Sheep MeSH
- THP-1 Cells MeSH
- Cell Survival drug effects MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Cytolytic leukotoxins of the repeat in toxin (RTX) family are large proteins excreted by gram-negative bacterial pathogens through the type 1 secretion system (T1SS). Due to low yields and poor stability in cultures of the original pathogens, it is useful to purify recombinant fatty-acylated RTX cytolysins from inclusion bodies produced in E. coli. Such preparations are, however, typically contaminated by high amounts of E. coli lipopolysaccharide (LPS or endotoxin). We report a simple procedure for purification of large amounts of biologically active and endotoxin-free RTX toxins. It is based on the common feature of RTX cytolysins that are T1SS-excreted as unfolded polypeptides and fold into a biologically active toxin only upon binding of calcium ions outside of the bacterial cell. Mimicking this process, the RTX proteins are solubilized from inclusion bodies with buffered 8 M urea, bound onto a suitable chromatographic medium under denaturing conditions and the contaminating LPS is removed through extensive on-column washes with buffers containing 6 to 8 M urea and 1% Triton X-100 or Triton X-114. Extensive on-column rinsing with 8 M urea buffer removes residual detergent and the eluted highly active RTX protein preparations then contain only trace amounts of LPS. The procedure is exemplified using four prototypic RTX cytolysins, the Bordetella pertussis CyaA and the hemolysins of Escherichia coli (HlyA), Kingella kingae (RtxA), and Actinobacillus pleuropneumoniae (ApxIA).
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20006243
- 003
- CZ-PrNML
- 005
- 20200518132446.0
- 007
- ta
- 008
- 200511s2019 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/toxins11060336 $2 doi
- 035 __
- $a (PubMed)31212877
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Stanek, Ondrej $u Institute of Microbiology of the CAS, Videnska 1083, 142 20 Prague, Czech Republic. stanek@biomed.cas.cz.
- 245 10
- $a Rapid Purification of Endotoxin-Free RTX Toxins / $c O. Stanek, J. Masin, R. Osicka, D. Jurnecka, A. Osickova, P. Sebo,
- 520 9_
- $a Cytolytic leukotoxins of the repeat in toxin (RTX) family are large proteins excreted by gram-negative bacterial pathogens through the type 1 secretion system (T1SS). Due to low yields and poor stability in cultures of the original pathogens, it is useful to purify recombinant fatty-acylated RTX cytolysins from inclusion bodies produced in E. coli. Such preparations are, however, typically contaminated by high amounts of E. coli lipopolysaccharide (LPS or endotoxin). We report a simple procedure for purification of large amounts of biologically active and endotoxin-free RTX toxins. It is based on the common feature of RTX cytolysins that are T1SS-excreted as unfolded polypeptides and fold into a biologically active toxin only upon binding of calcium ions outside of the bacterial cell. Mimicking this process, the RTX proteins are solubilized from inclusion bodies with buffered 8 M urea, bound onto a suitable chromatographic medium under denaturing conditions and the contaminating LPS is removed through extensive on-column washes with buffers containing 6 to 8 M urea and 1% Triton X-100 or Triton X-114. Extensive on-column rinsing with 8 M urea buffer removes residual detergent and the eluted highly active RTX protein preparations then contain only trace amounts of LPS. The procedure is exemplified using four prototypic RTX cytolysins, the Bordetella pertussis CyaA and the hemolysins of Escherichia coli (HlyA), Kingella kingae (RtxA), and Actinobacillus pleuropneumoniae (ApxIA).
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a bakteriální proteiny $x izolace a purifikace $x toxicita $7 D001426
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a viabilita buněk $x účinky léků $7 D002470
- 650 _2
- $a cytotoxiny $x izolace a purifikace $x toxicita $7 D003603
- 650 _2
- $a detergenty $x chemie $7 D003902
- 650 _2
- $a erytrocyty $x účinky léků $7 D004912
- 650 _2
- $a Escherichia coli $x metabolismus $7 D004926
- 650 _2
- $a hemolyziny $x izolace a purifikace $x toxicita $7 D006460
- 650 _2
- $a hemolýza $7 D006461
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lipopolysacharidy $x analýza $7 D008070
- 650 _2
- $a oktoxynol $x chemie $7 D017830
- 650 _2
- $a ovce $7 D012756
- 650 _2
- $a THP-1 buňky $7 D000074084
- 650 _2
- $a močovina $x chemie $7 D014508
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Masin, Jiri $u Institute of Microbiology of the CAS, Videnska 1083, 142 20 Prague, Czech Republic. masin@biomed.cas.cz.
- 700 1_
- $a Osicka, Radim $u Institute of Microbiology of the CAS, Videnska 1083, 142 20 Prague, Czech Republic. osicka@biomed.cas.cz.
- 700 1_
- $a Jurnecka, David $u Institute of Microbiology of the CAS, Videnska 1083, 142 20 Prague, Czech Republic. david.jurnecka@biomed.cas.cz. Faculty of Science, Charles University, Hlavova 2030, 128 43 Prague, Czech Republic. david.jurnecka@biomed.cas.cz.
- 700 1_
- $a Osickova, Adriana $u Institute of Microbiology of the CAS, Videnska 1083, 142 20 Prague, Czech Republic. osickova@biomed.cas.cz. Faculty of Science, Charles University, Hlavova 2030, 128 43 Prague, Czech Republic. osickova@biomed.cas.cz.
- 700 1_
- $a Sebo, Peter $u Institute of Microbiology of the CAS, Videnska 1083, 142 20 Prague, Czech Republic. sebo@biomed.cas.cz.
- 773 0_
- $w MED00177194 $t Toxins $x 2072-6651 $g Roč. 11, č. 6 (2019)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31212877 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20200518132446 $b ABA008
- 999 __
- $a ok $b bmc $g 1525101 $s 1096299
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 11 $c 6 $e 20190612 $i 2072-6651 $m Toxins $n Toxins $x MED00177194
- LZP __
- $a Pubmed-20200511